CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations

 CTI Appoints Monique Greer, Senior Vice President, Corporate Communications
                            and Investor Relations

PR Newswire

SEATTLE, Nov. 12, 2012

SEATTLE, Nov. 12, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ
and MTA: CTIC), a company focused on translating science into novel cancer
therapies, announced today the appointment of Monique Greer as Senior Vice
President, Corporate Communications and Investor Relations. Ms. Greer will be
responsible for leading CTI's external and internal communications strategies
and will report directly to James A. Bianco, M.D., President and Chief
Executive Officer.

"Monique is a key hire to drive consistent communications globally, as we
transition from a product development organization to a commercial
organization," said James Bianco. "She has an excellent reputation in the
biotechnology industry for developing and executing strategic, results-driven
communications programs that advance business objectives. We believe
Monique's recent hematology/oncology commercial experience, management
discipline and entrepreneurial drive will serve CTI well as we execute on our
global strategy to deliver results for both patients and shareholders."

Ms. Greer has more than 17 years' experience planning and implementing
strategic biotech/healthcare corporate communications, investor and media
relations, and advocacy relations programs in support of product development,
commercialization and strategic initiatives. Most recently, Ms. Greer was
Vice President of Corporate Communications and Investor Relations for Allos
Therapeutics, Inc. (recently acquired by Spectrum Pharmaceuticals). Ms. Greer
served previously as Senior Associate in the Corporate Communications and
Investor Relations practice for WCG, a global communications agency, where she
created and implemented integrated, strategic communications programs for the
firm's clients in the United States and Europe. She has also served as Senior
Director, Corporate Communications and Investor Relations for Dendreon
Corporation, as well as Director, Corporate Communications for Heska
Corporation. Ms. Greer received a bachelor of science in Business
Administration from Northeastern University.

About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to
developing an integrated portfolio of oncology products aimed at making cancer
more treatable. For additional information, please visit
www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site,
http://www.CellTherapeutics.com/investors_alert

Contact:
Ed Bell
T: 206.282.7100
F: 206.272.4434
E: invest@ctiseattle.com
www.CellTherapeutics.com/investors

SOURCE Cell Therapeutics, Inc.

Website: http://www.celltherapeutics.com